2020
DOI: 10.3892/etm.2020.8566
|View full text |Cite
|
Sign up to set email alerts
|

Anxiety and depression in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a Chinese survey

Abstract: Limited studies have focused on mental symptoms (anxiety and depression) and their impact on quality of life (QoL) in patients with pulmonary hypertension (PH). The objective of the present study was to assess the prevalence of anxiety and depression and their association with QoL in patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic PH (CTEPH) in a Chinese population. Patients diagnosed with PH by right heart catheterization between March 2015 and February 2016 were recruited. QoL … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
32
1
2

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(37 citation statements)
references
References 27 publications
2
32
1
2
Order By: Relevance
“…Compared to the given control group, this prevalence is significantly higher. However, previous studies found anxiety disorders in PH patients in a range of 13 to 45.5% in non-pandemic situations [ 27 , 28 , 29 ]. Accordingly, the level of anxiety seems to be not significantly higher during the COVID-19 pandemic.…”
Section: Discussionmentioning
confidence: 95%
“…Compared to the given control group, this prevalence is significantly higher. However, previous studies found anxiety disorders in PH patients in a range of 13 to 45.5% in non-pandemic situations [ 27 , 28 , 29 ]. Accordingly, the level of anxiety seems to be not significantly higher during the COVID-19 pandemic.…”
Section: Discussionmentioning
confidence: 95%
“…Hence, it is not surprising that some patients may develop an adjustment disorder, which may evolve into other psychiatric conditions during the course of their illness. Symptoms of depression and anxiety have been reported in up to 50% of patients with PAH (4)(5)(6)(7)(8)(9)(10)(11)(12). It is likely that such symptoms have a profound effect on the quality of life (QoL) in the affected patients.…”
Section: Introductionmentioning
confidence: 99%
“…This may be related to the fact that many PAH patients struggle to have a positive outlook, as there is a high rate of anxiety and depression in PAH patients. 29,30 Patient interviews suggested that term "worsening" had a strong negative connotation. Patients also wanted to hear providers focus on "reducing symptoms" as opposed to making them "feel normal", which is expected, given that symptoms are associated with reduction in quality of life and increased burden in patients.…”
Section: Discussionmentioning
confidence: 99%